Thalassaemia Pipeline Highlights - 2018

  • ID: 4516463
  • Report
  • Fore Pharma
20 % OFF
until Dec 31st 2018
1 of 3
The latest report Thalassaemia Pipeline Highlights - 2018, provides most up-to-date information on key pipeline products in the global Thalassaemia market. It covers emerging therapies for Thalassaemia in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Thalassaemia pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Thalassaemia pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Thalassaemia pipeline products by the company.

Short-term Launch Highlights:
Find out which Thalassaemia pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:
  • Thalassaemia phase 3 clinical trial pipeline products
  • Thalassaemia phase 2 clinical trial pipeline products
  • Thalassaemia phase 1 clinical trial pipeline products
  • Thalassaemia preclinical research pipeline products
  • Thalassaemia discovery stage pipeline products
  • Thalassaemia pipeline products short-term launch highlights
Note: Product cover images may vary from those shown
2 of 3
1. Thalassaemia Pipeline by Stages
2. Thalassaemia Pipeline by Drug Class
3. Thalassaemia Pipeline by Company
4. Thalassaemia Phase 3 Clinical Trial Insights
5. Thalassaemia Phase 2 Clinical Trial Insights
6. Thalassaemia Phase 1 Clinical Trial Insights
7. Thalassaemia Preclinical Research Insights
8. Thalassaemia Discovery Stage Insights
9. Appendix
10. Research Methodology

List of Tables
Table 1: Thalassaemia Phase 3 Clinical Trials, 2018
Table 2: Thalassaemia Phase 2 Clinical Trials, 2018
Table 3: Thalassaemia Phase 1 Clinical Trials, 2018
Table 4: Thalassaemia Preclinical Research, 2018
Table 5: Thalassaemia Discovery Stage, 2018

List of Figures
Figures 1: Thalassaemia Pipeline Molecules by Clinical Trials Stage, 2018
Figure 2: Thalassaemia Pipeline Molecules by Drug Class, 2018
Figure 3: Thalassaemia Pipeline Molecules by Company, 2018
Figure 4: Thalassaemia Phase 3 Clinical Trial Highlights, 2018
Figure 5: Thalassaemia Phase 2 Clinical Trial Highlights, 2018
Figure 6: Thalassaemia Phase 1 Clinical Trial Highlights, 2018
Figure 7: Thalassaemia Preclinical Research Highlights, 2018
Figure 8: Thalassaemia Discovery Stage Highlights, 2018
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll